DCF — SOUTHWESTERN VERMONT MEDICAL CENTER
Enterprise Value: $-136.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-136.7M
Enterprise Value
$-45.7M
PV of Cash Flows
$-91.0M
PV of Terminal Value
$-146.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $159.3M | $-7.2M | -4.0% | $-13.9M | $-12.6M |
| Year 2 | $164.0M | $-5.7M | -3.0% | $-12.7M | $-10.5M |
| Year 3 | $169.0M | $-4.2M | -2.0% | $-11.4M | $-8.5M |
| Year 4 | $174.0M | $-3.5M | -2.0% | $-10.8M | $-7.4M |
| Year 5 | $179.2M | $-3.1M | -2.0% | $-10.7M | $-6.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-136.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$154.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999838306534
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5